Med-X Acquires 49% Interest in NAPCO Painting Contractors
Med-X Acquires 49% Interest in NAPCO Painting Contractors
Med-X Makes Strategic Minority Investment in a Napa Valley Based Green Scene Painting Company
Med-X對一家總部位於納帕谷的綠色場景繪畫公司進行戰略少數股權投資
Management Exploring Nature-Cide Insecticidal Paint Additive Alongside NAPCO Team
管理層與 NAPCO 團隊一起探索 Nature-Cide 殺蟲塗料添加劑
LOS ANGELES, CA / ACCESSWIRE / October 4, 2023 / Med-X, Inc., a leading innovator of all-natural green scene solutions addressing the pest control, health and wellness markets, announced today that it has signed a definitive agreement to acquire a 49% minority interest in NAPCO Painting Contractors, Inc. ("NAPCO"), a popular green scene painting contractor in the Napa Valley region of California.
加利福尼亞州洛杉磯/ACCESSWIRE/2023 年 10 月 4 日/ Med-X, Inc.， 一家針對害蟲防治、健康和保健市場的全天然綠色場景解決方案的領先創新者今天宣佈，它已簽署最終協議，收購其49％的少數股權 NAPCO 塗裝承包商有限公司 （“NAPCO”），加利福尼亞納帕谷地區一家受歡迎的綠色場景繪畫承包商。
Having been in business for over 20 years, NAPCO is a full-service painting company serving wine country in Napa Valley, California. The Company's green scene approach is popular with wineries, resorts, commercial businesses and some of the most amazing corporate retreats and residential homes in the region, aligning well with Med-X's core values. NAPCO is licensed by the California Contractors State License Board and is a proud member of the Napa Chamber of Commerce.
NAPCO已經經營了20多年，是一家提供全方位服務的繪畫公司，爲加利福尼亞州納帕谷的葡萄酒之鄉提供服務。該公司的綠色場景方法深受釀酒廠、度假村、商業企業以及該地區一些最令人驚歎的企業度假勝地和住宅的歡迎，與Med-X的核心價值觀非常吻合。NAPCO已獲得加州承包商州執照委員會的許可，並且是納帕商會的驕傲會員。
Matthew Mills, Chief Executive Officer of Med-X, commented: "Our strategic minority investment and budding partnership with NAPCO aligns with our mission of providing safer green scene solutions to consumers everywhere. Their business complements our Integrated Pest Management capabilities with a robust services platform in the Northern California region - while concurrently driving exciting product synergies, including the potential to fully deploy the Nature-Cide all-natural insecticidal paint additive for use in NAPCO projects throughout the region and beyond.
Med-X首席執行官Matthew Mills評論說：“我們的戰略少數股權投資以及與NAPCO的萌芽合作伙伴關係符合我們的使命，即爲世界各地的消費者提供更安全的綠色場景解決方案。他們的業務通過在北加州地區的強大服務平台補充了我們的綜合害蟲管理能力，同時推動了令人興奮的產品協同效應，包括有可能全面部署Nature-Cide全天然殺蟲塗料添加劑，用於該地區及其他地區的NAPCO項目。
"This strategic minority investment represents an important steppingstone towards our goal of expanding a sector that enhances the solution for pest pressure in many environments. As we continue to progress, I look forward to providing our shareholders with additional updates on our efforts to drive and create sustainable solutions for long-term value for my fellow shareholders," concluded Mills.
“這項戰略性少數股權投資是我們朝着擴大一個在許多環境中增強害蟲壓力解決方案的行業的目標邁出的重要一步。隨着我們的不斷進步，我期待向我們的股東提供更多最新信息，說明我們努力推動和創造可持續的解決方案，爲其他股東創造長期價值，” 米爾斯總結道。
"We are very excited to position ourselves with Med-X to help advance painting technology and create a new pest control service for NAPCO customers. Our NAPCO customers are already incredibly conscious about the environment, so cutting edge green solutions like the Nature-Cide paint additives, pest management products and sustainably focused thinking is exactly why NAPCO and Med-X, Inc. are a perfect match," added NAPCO CEO Joseph Winograde.
“我們很高興能與Med-X合作，幫助推進塗裝技術，爲NAPCO客戶提供新的害蟲防治服務。我們的NAPCO客戶對環境的意識已經令人難以置信，因此，Nature-Cide塗料添加劑、害蟲管理產品和以可持續爲重點的思維等尖端綠色解決方案正是NAPCO和Med-X, Inc.完美匹配的原因。” NAPCO首席執行官約瑟夫·溫諾格拉德補充說。
About Med-X, Inc.
關於 Med-X, Inc.
Med-X, Inc. is a leading innovator of biological pest control solutions addressing both consumer and professional markets globally. Nature-Cide - the Company's flagship product line - is a safer, all-natural alternative to conventional chemical products, formulated to kill or repel a wide variety of pests. Med-X's comprehensive go-to-market strategy includes leveraging strategic partnerships alongside an integrated e-commerce, brick and mortar and on-site services presence in key markets. For more information, please visit our website at .
Med-X, Inc. 是生物害蟲防治解決方案的領先創新者，面向全球消費者和專業市場。Nature-Cide是公司的旗艦產品線，是傳統化學產品的更安全、全天然的替代品，其配方旨在殺死或擊退各種害蟲。Med-X 的全面進入市場戰略包括利用戰略合作伙伴關係，以及在關鍵市場開展綜合電子商務、實體店和現場服務。欲了解更多信息，請訪問我們的網站 。
Disclaimer and Forward-Looking Statements
免責聲明和前瞻性陳述
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities. Any offers, solicitations or offers to buy, or any sale of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). This announcement is being issued in accordance with Rule 135 of the Securities Act. This press release may contain forward-looking statements regarding projected business performance, operating results, financial condition, and other aspects of the company, expressed by such language as "expected," "anticipated," "projected" and "forecasted." Please be advised that such statements are estimates only and there is no assurance that the results stated or implied by forward-looking statements will actually be realized by the company. Forward-looking statements may be based on management assumptions that prove to be wrong. The Company and its business are subject to substantial risks and potential events beyond its control that would cause material differences between predicted results and actual results, including the Company incurring operating losses and experiencing unexpected material adverse events. Of note for this transaction, Joseph Winograde - the seller of NAPCO - is a relative of Lester Winograde, corporate counsel for Med-X.
本新聞稿不構成出售要約或要約購買任何證券。任何要約、招標或要約購買或出售證券都將根據經修訂的1933年《證券法》（“證券法”）的註冊要求提出。本公告根據《證券法》第135條發佈。本新聞稿可能包含有關公司預期業務業績、經營業績、財務狀況和其他方面的前瞻性陳述，這些陳述以 “預期”、“預期”、“預期”、“預期” 和 “預測” 之類的語言表示。請注意，此類陳述僅爲估計值，無法保證前瞻性陳述中陳述或暗示的業績將由公司實際實現。前瞻性陳述可能基於被證明是錯誤的管理層假設。公司及其業務面臨其無法控制的重大風險和潛在事件，這些風險和事件將導致預測業績與實際業績之間存在重大差異，包括公司蒙受營業虧損和經歷意想不到的重大不利事件。在這筆交易中，值得注意的是，NAPCO的賣方約瑟夫·溫諾格拉德是Med-X公司法律顧問萊斯特·溫諾格拉德的親屬。
Investor Relations Contact
Lucas Zimmerman
Director
MZ Group - MZ North America
262-357-2918
MXRX@mzgroup.us
投資者關係聯繫人
盧卡斯·齊默爾曼
導演
MZ 集團-MZ 北美
262-357-2918
MXRX@mzgroup.us
SOURCE: Med-X, Inc.
來源： Med-X, Inc.
譯文內容由第三人軟體翻譯。